D
Emergent BioSolutions Inc. EBS
$9.11 -$0.1163-1.26% NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 140.90M 222.20M 194.70M 293.80M 254.70M
Total Other Revenue -- -- -- -- --
Total Revenue 140.90M 222.20M 194.70M 293.80M 254.70M
Cost of Revenue 80.20M 102.80M 58.20M 129.60M 320.20M
Gross Profit 60.70M 119.40M 136.50M 164.20M -65.50M
SG&A Expenses 44.00M 52.70M 60.70M 75.90M 77.30M
Depreciation & Amortization 16.20M 16.30M 16.30M 16.30M 16.30M
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 140.40M 171.80M 199.00M 221.80M 413.80M
Operating Income 500.00K 50.40M -4.30M 72.00M -159.10M
Income Before Tax -16.80M 92.70M -27.60M 142.40M -269.80M
Income Tax Expenses -4.80M 24.70M 3.70M 27.60M 13.30M
Earnings from Continuing Operations -12.00M 68.00M -31.30M 114.80M -283.10M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -12.00M 68.00M -31.30M 114.80M -283.10M
EBIT 500.00K 50.40M -4.30M 72.00M -159.10M
EBITDA 23.50M 75.20M 21.00M 97.70M -131.50M
EPS Basic -0.22 1.25 -0.58 2.16 -5.38
Normalized Basic EPS -0.21 1.12 -0.25 1.01 -2.20
EPS Diluted -0.22 1.19 -0.58 2.06 -5.38
Normalized Diluted EPS -0.21 1.06 -0.25 0.96 -2.20
Average Basic Shares Outstanding 54.20M 54.40M 54.20M 53.10M 52.60M
Average Diluted Shares Outstanding 54.20M 57.30M 54.20M 55.60M 52.60M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --